ProCE Banner Activity

Circulating Tumor DNA Analysis From Pts With mCRC Who Were Treated With Panitumumab in ASPECCT

Slideset Download
Conference Coverage
Next-generation sequencing of circulating tumor DNA revealed complex mutational changes with panitumumab treatment.

Released: June 08, 2017

Expiration: June 07, 2018

No longer available for credit.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants by

AbbVie

Amgen, Inc.

AstraZeneca

Celgene

Genentech Roche Virology

Halozyme

Incyte

Merck Oncology